209 related articles for article (PubMed ID: 31101621)
1. Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma.
Wu X; Stenson M; Abeykoon J; Nowakowski K; Zhang L; Lawson J; Wellik L; Li Y; Krull J; Wenzl K; Novak AJ; Ansell SM; Bishop GA; Billadeau DD; Peng KW; Giles F; Schmitt DM; Witzig TE
Blood; 2019 Jul; 134(4):363-373. PubMed ID: 31101621
[TBL] [Abstract][Full Text] [Related]
2. Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth.
Koo J; Yue P; Gal AA; Khuri FR; Sun SY
Cancer Res; 2014 May; 74(9):2555-68. PubMed ID: 24626091
[TBL] [Abstract][Full Text] [Related]
3. GSK3β, but not GSK3α, inhibits the neuronal differentiation of neural progenitor cells as a downstream target of mammalian target of rapamycin complex1.
Ahn J; Jang J; Choi J; Lee J; Oh SH; Lee J; Yoon K; Kim S
Stem Cells Dev; 2014 May; 23(10):1121-33. PubMed ID: 24397546
[TBL] [Abstract][Full Text] [Related]
4. Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
Madhunapantula SV; Sharma A; Gowda R; Robertson GP
Pigment Cell Melanoma Res; 2013 Nov; 26(6):886-99. PubMed ID: 24034838
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3β is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor.
Rubio-Patiño C; Palmeri CM; Pérez-Perarnau A; Cosialls AM; Moncunill-Massaguer C; González-Gironès DM; Pons-Hernández L; López JM; Ventura F; Gil J; Pons G; Iglesias-Serret D
Mol Endocrinol; 2012 Sep; 26(9):1508-20. PubMed ID: 22771494
[TBL] [Abstract][Full Text] [Related]
6. Opposing Roles of GSK3α and GSK3β Phosphorylation in Platelet Function and Thrombosis.
Moore SF; Agbani EO; Wersäll A; Poole AW; Williams CM; Zhao X; Li Y; Hutchinson JL; Hunter RW; Hers I
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638997
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma.
Abe K; Yamamoto N; Domoto T; Bolidong D; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Inatani H; Aoki Y; Higuchi T; Taniguchi Y; Yonezawa H; Araki Y; Aiba H; Minamoto T; Tsuchiya H
Cancer Sci; 2020 Feb; 111(2):429-440. PubMed ID: 31808966
[TBL] [Abstract][Full Text] [Related]
8. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
Pardo M; Abrial E; Jope RS; Beurel E
Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the Role of Glycogen Synthase Kinase-3α/β in Macrophage Polarization and the Regulation of Pro-Atherogenic Pathways in Cultured Ldlr
Patel S; Werstuck G
Front Immunol; 2021; 12():676752. PubMed ID: 34394077
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
Chen L; Ren F; Zhang H; Wen T; Piao Z; Zhou L; Zheng S; Zhang J; Chen Y; Han Y; Duan Z; Ma Y
PLoS One; 2012; 7(9):e45202. PubMed ID: 23028846
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo.
Lee HC; Tsai JN; Liao PY; Tsai WY; Lin KY; Chuang CC; Sun CK; Chang WC; Tsai HJ
BMC Dev Biol; 2007 Aug; 7():93. PubMed ID: 17683539
[TBL] [Abstract][Full Text] [Related]
12. GSK3 inhibitors stabilize Wee1 and reduce cerebellar granule cell progenitor proliferation.
Penas C; Mishra JK; Wood SD; Schürer SC; Roush WR; Ayad NG
Cell Cycle; 2015; 14(3):417-24. PubMed ID: 25616418
[TBL] [Abstract][Full Text] [Related]
13. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
[TBL] [Abstract][Full Text] [Related]
14. The Glycogen Synthase Kinase 3α and β Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus.
Cortés-Vieyra R; Silva-García O; Oviedo-Boyso J; Huante-Mendoza A; Bravo-Patiño A; Valdez-Alarcón JJ; Finlay BB; Baizabal-Aguirre VM
PLoS One; 2015; 10(7):e0132867. PubMed ID: 26200352
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
16. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
17. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis.
Spokoini R; Kfir-Erenfeld S; Yefenof E; Sionov RV
Mol Endocrinol; 2010 Jun; 24(6):1136-50. PubMed ID: 20371704
[TBL] [Abstract][Full Text] [Related]
19. Isoform-specific requirement for GSK3α in sperm for male fertility.
Bhattacharjee R; Goswami S; Dey S; Gangoda M; Brothag C; Eisa A; Woodgett J; Phiel C; Kline D; Vijayaraghavan S
Biol Reprod; 2018 Aug; 99(2):384-394. PubMed ID: 29385396
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer.
Pal K; Cao Y; Gaisina IN; Bhattacharya S; Dutta SK; Wang E; Gunosewoyo H; Kozikowski AP; Billadeau DD; Mukhopadhyay D
Mol Cancer Ther; 2014 Feb; 13(2):285-96. PubMed ID: 24327518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
